News

News Highlights

  • July 30, 2021 — With the issuance by the United States Patent and Trademark Office (USPTO) of the patent, “Cell Culture Incubators with Integrated Imaging Systems”, Thrive’s intellectual property portfolio now includes 71 patent applications in the U.S., China, Europe and Japan, of which 22 have been issued. 

 

  • June 14, 2021 — Thrive Bioscience releases a new video providing a comprehensive overview of the CellAssist, which combines a state of the art imaging system coupled with intuitive software to provide high-resolution images with excellent registration. The unique capabilities and applications outlined in the video enable researchers to gain a deeper insight into cell dynamics and greatly improve the reproducibility and accuracy of cell culture experiments. Watch the full CellAssist demo video at: www.thrivebio.com/the-cellassist

 

  • May 12, 2021 — Thrive Bioscience releases a new video to cover a recently conducted interview with Steven Sheridan, Ph.D., Senior Research Investigator, Center for Genomic Medicine, Massachusetts General Hospital. During the “Researcher’s Insight” interview, Dr. Sheridan provided an in-depth overview of how the CellAssist addresses his laboratory’s cell culture pain points. Watch the full interview at: www.thrivebio.com/the-cellassist

 

  • April 26, 2021 — Thrive Bioscience announces the promotion of Michael Moody, M.S., from the position of Director, Software Development to Vice President, Software Engineering.

 

  • February 25, 2021 — Thrive Bioscience promotes Ira Schaefer, J.D., from the position of Vice President, Intellectual Property to General Counsel. Mr. Schaefer has overseen the growth of Thrive’s important IP portfolio upon joining Thrive from Hogan Lovells.

 

  • February 18, 2021 — Thrive Bioscience enters into a distribution agreement for the CellAssist with AS ONE CORPORATION, headquartered in Osaka, Japan. AS ONE is a leading supplier of research instruments in Japan.

 

  • January 7, 2021 — Thrive Bioscience enters into a distribution agreement with J.C. Gonzalez, Inc., a leading provider for laboratory equipment and consumables in San Germán, Puerto Rico for distribution of the CellAssist family products in Puerto Rico.

 

  • January 2, 2021 — Thrive Bioscience enters into a distribution agreement with D-Mark Biosciences, a premier provider for laboratory equipment and consumables in Scarborough, Ontario to market the CellAssist family products in Canada.
  • October 5, 2020 — Thrive Bioscience introduces the CellAssist® which enables cell culture researchers to image, analyze, and document all cells, plates, reagents, and workflow details in a centralized database.

 

  • October 1, 2020 — Thrive Bioscience announces filing of four patent applications for improving cell culture utilizing technologies in the fields of the Internet of Things (IoT), blockchain, image processing and automatic focusing.

 

  • September 1, 2020 — Thrive Bioscience presents at the AI, Big Data, and Digital Health Conference on September 8, 2020.

 

  • June 8, 2020 – Thrive Bioscience presents at the MedInvest Infectious Disease and Immunology Conference on June 15, 2020.

 

  • May 15, 2020 — Thrive Bioscience named one of “50 Fastest Growing Companies of 2020” by Silicon Review.

 

  • March 30, 2020 — Herb Kenny, former Vice President of Global Sales, Scientific Instruments at Thermo Fisher Scientific, joins Thrive Bioscience as Chief Commercial Officer, completing the senior management team for commercializing Thrive Bioscience’s family of products to significantly improve cell culture.

 

  • December 31, 2019 — Thrive Bioscience in December completes first five sales of its CellAssist instrument with shipments to commercial customers in Japan, Korea and the U.S.
  • December 31, 2019 — Thrive Bioscience in December completes first five sales of its CellAssist instrument with shipments to commercial customers in Japan, Korea and the U.S.

 

  • November 1, 2019 — Thrive Bioscience files U.S. patent applications on blockchain and the internet of things (IOT) to cell culture. Thrive’s patent portfolio now consists of over 50 applications related to cell culture of which eight have issued.

 

  • August 9, 2019 — Thrive Bioscience named one of 20 Most Promising Biotech Solution Providers 2019 and one of 20 Best Biotech Companies of 2019 by CIO (Chief Information Officer) Review.

 

  • June 5, 2019 — Jeff Goldman, former R&D Manager at Agilent Technologies, joins Thrive Bioscience as Vice President of Engineering & Manufacturing to oversee the productization and manufacturing of Thrive’s family of cell culture instruments.

 

  • January 1, 2019 — Ira J. Schaefer, Esq., former Partner at Hogan Lovells, joins Thrive Bioscience as Vice President of Intellectual Property to oversee and continue the expansion of Thrive Bioscience’s intellectual property portfolio.
  • September 17, 2018 — Takashi Kiyoizumi, M.D., Ph.D., M.B.A, joins Thrive Bioscience as Executive Vice President of International and Senior Advisor to CEO.

 

  • April 5, 2018 — Thrive Bioscience licenses-in on an exclusive basis from an internationally-recognized research institute, an imaging-related portfolio of eight patent applications of which six have issued. Thrive Bioscience’s patent portfolio now includes 34 patent applications of which seven have issued.
  • July 7, 2016 — Thrive Bioscience announces instruments and services agreement with the Harvard Stem Cell Institute.